TC BioPharm (Holdings) PLC (TCBP)
1.46
+0.01
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2021 | 5.392M |
Date | Value |
---|---|
September 30, 2020 | 4.571M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
4.571M
Minimum
Sep 2020
5.392M
Maximum
Sep 2021
4.982M
Average
4.982M
Median
Cash from Financing (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 0.074M |
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | -0.0533M |
Autolus Therapeutics PLC | 0.023M |
Mereo BioPharma Group PLC | -- |
Cash from Financing (Quarterly) Related Metrics
Free Cash Flow | -13.42M |
Free Cash Flow Yield | -2.98K% |